Multicenter Study for the Validation of an AI-based ECG Platform for Early Cardiac Amyloidosis Diagnosis

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

May 27, 2025

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Transthyretin Cardiac Amyloidosis
Trial Locations (6)

Unknown

NOT_YET_RECRUITING

Centre Hospitalier Universitaire de Toulouse, Toulouse

NOT_YET_RECRUITING

Careggi University Hospital, Florence

NOT_YET_RECRUITING

United Hospitals of Trieste University Hospital, Trieste

RECRUITING

Hospital Juan Ramón Jiménez, Huelva

RECRUITING

Hospital Universitario Son Llatzer, Palma de Mallorca

NOT_YET_RECRUITING

Hospital Universitario Donostia, San Sebastián

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Idoven 1903 S.L.

INDUSTRY